TABLE 4.
Domaina | GO term | Gene(s) | Upb | Genes | Downc |
---|---|---|---|---|---|
Oncogenes | |||||
BP | Signaling | BCL9L, RHOH, CNKSR2, RASA3 | 4 | RAB7B, RASGEF1C, RASSF6, ROS1, MET | 5 |
BP | Biological regulation | BCL9L, RHOH, CNKSR2, RASA3, TIAM2 | 5 | RAB7B, RASGEF1C, RASSF6, ROS1, MET, RAB11FIP3 | 6 |
BP | Regulation of biological process | BCL9L, RHOH, CNKSR2, RASA3, TIAM2 | 5 | RAB7B, RASGEF1C, RASSF6, ROS1, MET, RAB11FIP3 | 6 |
BP | Regulation of cellular process | BCL9L, RHOH, CNKSR2, RASA3, TIAM2 | 5 | RAB7B, RASGEF1C, RASSF6, ROS1, MET, RAB11FIP3 | 6 |
BP | Signal transduction | BCL9L, RHOH, CNKSR2, RASA3 | 4 | RAB7B, RASGEF1C, RASSF6, ROS1, MET | 5 |
Tumor suppressor genes | |||||
BP | Intracellular estrogen receptor signaling pathway | 0 | SRC, TP63 | 2 | |
BP | Apoptotic signaling pathway | HSPH1 | 1 | SRC, TP63 | 2 |
BP | Regulation of apoptotic signaling pathway | HSPH1 | 1 | SRC, TP63 | 2 |
Virus-associated genes | |||||
BP | Regulation of gene expression | 0 | MAFB, YES1, ETS2, ERBB2, YAP1 | 5 | |
BP | Nucleic acid-templated transcription | 0 | MAFB, YES1, ETS2, ERBB2, YAP1 | 5 | |
BP | Transcription, DNA templated | 0 | MAFB, YES1, ETS2, ERBB2, YAP1 | 5 | |
BP | Regulation of RNA biosynthetic process | 0 | MAFB, YES1, ETS2, ERBB2, YAP1 | 5 | |
BP | Regulation of nucleic acid-templated transcription | 0 | MAFB, YES1, ETS2, ERBB2, YAP1 | 5 | |
BP | Regulation of transcription, DNA templated | 0 | MAFB, YES1, ETS2, ERBB2, YAP1 | 5 | |
BP | Positive regulation of transcription, DNA templated | 0 | YES1, ETS2, ERBB2, YAP1 | 4 | |
BP | Positive regulation of gene expression | 0 | YES1, ETS2, ERBB2, YAP1 | 4 | |
BP | Positive regulation of RNA biosynthetic process | 0 | YES1, ETS2, ERBB2, YAP1 | 4 | |
BP | Positive regulation of nucleic acid-templated transcription | 0 | YES1, ETS2, ERBB2, YAP1 | 4 | |
Immune response and cytokine genes | |||||
BP | Regulation of signaling receptor activity | IL18 | 1 | TNFSF15, TGFB2, IL8L1, IL8L2, IL34, IL-1BETA | 6 |
BP | Cytokine-mediated signaling pathway | IL18 | 1 | LIFR, ACKR2, IL17REL, CCR6, IL8L1, IL1RL1, IL8L2, IL1R1 | 8 |
BP | Cell activation | IL18, BANK1 | 2 | CCR6, IL8L1, IL1RL1, IL8L2, IL-1BETA | 5 |
BP | Leukocyte activation | IL18, BANK1 | 2 | CCR6, IL8L1, IL1RL1, IL8L2, IL-1BETA | 5 |
BP | Regulation of signaling | IL18, BANK1 | 2 | CXXC5, TNFSF15, TLR5, TGFB2, SOCS2, IL8L1, IL1RL1, IL8L2, IL34, IL-1BETA | 10 |
BP | Regulation of signal transduction | IL18, BANK1 | 2 | CXXC5, TNFSF15, TLR5, TGFB2, SOCS2, IL8L1, IL1RL1, IL8L2, IL34, IL-1BETA | 10 |
BP | Immune system process | IL18, BANK1, CD247 | 3 | CXCL14, TNFSF15, TLR5, TGFB2, CCR6, IL8L1, ALCAM, IL1RL1, IL8L2, CX3CL1, IL34, IL-1BETA | 12 |
BP | Regulation of immune system process | IL18, BANK1, CD247 | 3 | CXCL14, TLR5, TGFB2, CCR6, IL8L1, IL1RL1, IL8L2, IL34, IL-1BETA | 9 |
MF | Signaling receptor binding | IL18, BANK1, CD247 | 3 | LIFR, CXCL14, TNFSF15, TLR5, TGFB2, SOCS2, IL8L1, IL8L2, CX3CL1, IL34, IL-1BETA | 11 |
BP | Signaling | IL18, BANK1, CD247, CD3D | 4 | CXXC5, LIFR, ACKR2, CXCL14, TNFSF15, IL17REL, TLR5, TGFB2, SOCS2, CCR6, IL8L1, IL1RL1, IL8L2, IL34, IL-1BETA, IL1R1 | 16 |
BP | Signal transduction | IL18, BANK1, CD247, CD3D | 4 | CXXC5, LIFR, ACKR2, TNFSF15, IL17REL, TLR5, TGFB2, SOCS2, CCR6, IL8L1, IL1RL1, IL8L2, IL34, IL-1BETA, IL1R1 | 15 |
BP | Immune response | IL18, CD247 | 2 | CXCL14, TNFSF15, TLR5, TGFB2, CCR6, IL8L1, ALCAM, IL1RL1, IL8L2, CX3CL1, IL-1BETA | 11 |
BP | Positive regulation of immune system process | IL18, CD247 | 2 | CXCL14, TLR5, IL8L1, IL1RL1, IL8L2, IL34, IL-1BETA | 7 |
BP | Cell surface receptor signaling pathway | IL18, CD247, CD3D | 3 | LIFR, ACKR2, IL17REL, TGFB2, SOCS2, CCR6, IL8L1, IL1RL1, IL8L2, IL1R1 | 10 |
keg | KEGG pathways | IL18, CD1C, TNFRSF13C | 3 | LIFR, CXCL14, TNFSF15, TLR5, TGFB2, CCR6, IL8L1, ALCAM, IL8L2, CX3CL1, IL-1BETA, IL7, CX3CR1, IL1R1 | 14 |
keg | Cytokine-cytokine receptor interaction | IL18, TNFRSF13C | 2 | LIFR, CXCL14, TNFSF15, TGFB2, CCR6, IL8L1, IL8L2, CX3CL1, IL-1BETA, IL7, CX3CR1, IL1R1 | 12 |
BP | Chemokine-mediated signaling pathway | 0 | ACKR2, CCR6, IL8L1, IL8L2 | 4 | |
BP | Leukocyte migration | 0 | CXCL14, CCR6, IL8L1, IL8L2, IL-1BETA | 5 | |
BP | Regulation of leukocyte migration | 0 | CXCL14, CCR6, IL8L1, IL8L2 | 4 | |
keg | Toll-like receptor signaling pathway | 0 | TLR5, IL8L1, IL8L2, IL-1BETA | 4 |
MF, molecular function; BP, biological process; keg, KEGG pathways.
Up, upregulated.
Down, downregulated.